Oncotarget: Cell cycle arrest and anaphase catastrophe in malignant T-cells
Researchers report that pevonedistat inhibits NEDD8-activating enzyme, leading to cell cycle arrest and anaphase catastrophe in malignant T-cells. This effect may be coupled with immunomodulatory activity, suggesting pevonedistat as a potential therapeutic approach for T-cell lymphoma.